JP2012506439A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012506439A5 JP2012506439A5 JP2011533266A JP2011533266A JP2012506439A5 JP 2012506439 A5 JP2012506439 A5 JP 2012506439A5 JP 2011533266 A JP2011533266 A JP 2011533266A JP 2011533266 A JP2011533266 A JP 2011533266A JP 2012506439 A5 JP2012506439 A5 JP 2012506439A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- fluoro
- iodo
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 76
- -1 64 Cu Chemical class 0.000 claims 38
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000003545 alkoxy group Chemical group 0.000 claims 19
- 125000001188 haloalkyl group Chemical group 0.000 claims 16
- 238000000034 method Methods 0.000 claims 14
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 10
- 239000012453 solvate Substances 0.000 claims 9
- 125000004438 haloalkoxy group Chemical group 0.000 claims 8
- 125000005843 halogen group Chemical group 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 7
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 6
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims 5
- 238000012634 optical imaging Methods 0.000 claims 5
- 239000000758 substrate Substances 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- 238000003384 imaging method Methods 0.000 claims 3
- 238000001959 radiotherapy Methods 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 230000002285 radioactive effect Effects 0.000 claims 2
- 230000003439 radiotherapeutic effect Effects 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229910052796 boron Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 238000011503 in vivo imaging Methods 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Chemical group 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 238000002603 single-photon emission computed tomography Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10700108P | 2008-10-21 | 2008-10-21 | |
| US61/107,001 | 2008-10-21 | ||
| GBGB0819280.9A GB0819280D0 (en) | 2008-10-21 | 2008-10-21 | Imgaing and radiotherapy methods |
| GB0819280.9 | 2008-10-21 | ||
| PCT/US2009/061271 WO2010048144A2 (en) | 2008-10-21 | 2009-10-20 | Imaging and radiotherapy methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012506439A JP2012506439A (ja) | 2012-03-15 |
| JP2012506439A5 true JP2012506439A5 (enExample) | 2013-05-09 |
Family
ID=40097766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011533266A Pending JP2012506439A (ja) | 2008-10-21 | 2009-10-20 | イメージング及び放射線治療法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110286922A1 (enExample) |
| EP (1) | EP2349351A2 (enExample) |
| JP (1) | JP2012506439A (enExample) |
| KR (1) | KR20110074988A (enExample) |
| CN (1) | CN102186505A (enExample) |
| AU (1) | AU2009307783A1 (enExample) |
| BR (1) | BRPI0919690A2 (enExample) |
| CA (1) | CA2738955A1 (enExample) |
| GB (1) | GB0819280D0 (enExample) |
| MX (1) | MX2011004161A (enExample) |
| RU (1) | RU2011113996A (enExample) |
| WO (1) | WO2010048144A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8540968B2 (en) | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
| CN1929869B (zh) | 2004-03-02 | 2010-11-24 | 塞勒克塔有限公司 | 用于诊断和治疗癌症的磷脂类似物 |
| CU23844B1 (es) * | 2009-04-17 | 2012-10-15 | Ct De Neurociencias De Cuba | Procedimiento de obtención de nuevos derivados de naftaleno para el diagnóstico in vivo de la enfermedad de alzheimer |
| ES2959862T3 (es) * | 2009-06-12 | 2024-02-28 | Cellectar Inc | Compuestos eterfosfolipídicos para el tratamiento de cáncer y obtención de imágenes y detección de células madre cancerosas |
| JP2013515083A (ja) * | 2009-12-22 | 2013-05-02 | ジーイー・ヘルスケア・リミテッド | 癌幹細胞におけるａｌｄｈのインビボイメージング用アルデヒド |
| US9649394B2 (en) | 2010-11-22 | 2017-05-16 | The General Hospital Corporation | Compositions and methods for in vivo imaging |
| WO2013012754A1 (en) * | 2011-07-15 | 2013-01-24 | University Of Southern California | Boron-based dual imaging probes, compositions and methods for rapid aqueous f-18 labeling, and imaging methods using same |
| WO2013048832A1 (en) * | 2011-09-29 | 2013-04-04 | Ge Healthcare Limited | 18 f - labelled 6 - ( 2 - fluoroethoxy) - 2 - naphthaldehyde for detecting cancer stem cells |
| WO2013048811A1 (en) * | 2011-09-30 | 2013-04-04 | Ge Healthcare Limited | Imaging and radiotherapy methods for tumour stem cells |
| US8927732B2 (en) * | 2012-03-30 | 2015-01-06 | General Electric Company | Biotin stannane for HPLC-free radioiodination |
| WO2014145493A1 (en) * | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Radioactive substrates for aldehyde dehydrogenase |
| EP3450963A4 (en) * | 2016-04-28 | 2020-01-29 | National University Corporation Nagoya University | FLUORESCENT PROBE, METHOD FOR DETECTING FLUORESCENCE AND METHOD OF USING FLUORESCENT PROBE |
| FR3054564B1 (fr) * | 2016-07-28 | 2018-08-31 | Advanced Biodesign | Substrat specifique d'une isoenzyme de l'aldh |
| KR101941223B1 (ko) * | 2017-04-04 | 2019-01-22 | 을지대학교 산학협력단 | 복강경 수술용 삼중 융합영상장치 |
| JP2023025307A (ja) * | 2020-01-31 | 2023-02-22 | 国立大学法人 東京大学 | アルデヒドロゲナーゼ１ａ１検出用青色蛍光プローブ |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5876956A (en) * | 1995-05-15 | 1999-03-02 | Johns Hopkins University School Of Medicine | Methods for identification or purification of cells containing an enzymatic intracellular marker |
| WO2003093498A1 (en) * | 2002-04-29 | 2003-11-13 | The Ohio State University | Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic |
| GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
| GB0502277D0 (en) * | 2005-02-04 | 2005-03-09 | Amersham Plc | Novel imaging agents |
| US20080058316A1 (en) * | 2006-02-27 | 2008-03-06 | The Johns Hopkins University | Cancer treatment with gama-secretase inhibitors |
| US20080187938A1 (en) * | 2006-09-22 | 2008-08-07 | The Regents Of The University Of Michigan | ALDH1 As A Cancer Stem Cell Marker |
-
2008
- 2008-10-21 GB GBGB0819280.9A patent/GB0819280D0/en not_active Ceased
-
2009
- 2009-10-20 US US13/124,703 patent/US20110286922A1/en not_active Abandoned
- 2009-10-20 MX MX2011004161A patent/MX2011004161A/es not_active Application Discontinuation
- 2009-10-20 CN CN2009801423890A patent/CN102186505A/zh active Pending
- 2009-10-20 CA CA2738955A patent/CA2738955A1/en not_active Abandoned
- 2009-10-20 EP EP09749242A patent/EP2349351A2/en not_active Withdrawn
- 2009-10-20 JP JP2011533266A patent/JP2012506439A/ja active Pending
- 2009-10-20 WO PCT/US2009/061271 patent/WO2010048144A2/en not_active Ceased
- 2009-10-20 KR KR1020117008974A patent/KR20110074988A/ko not_active Withdrawn
- 2009-10-20 BR BRPI0919690A patent/BRPI0919690A2/pt not_active IP Right Cessation
- 2009-10-20 RU RU2011113996/15A patent/RU2011113996A/ru not_active Application Discontinuation
- 2009-10-20 AU AU2009307783A patent/AU2009307783A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012506439A5 (enExample) | ||
| RU2011113996A (ru) | Способы визуализации и радиотерапии | |
| CN101668547B (zh) | 选择缺氧组织的弱碱性2-硝基咪唑递送剂及其应用方法 | |
| EP2764406B1 (en) | Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties | |
| JP2010523599A5 (enExample) | ||
| TWI245764B (en) | Amyloid plaque aggregation inhibitors and diagnostic imaging agents | |
| CN101863924B (zh) | 99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法 | |
| EP2501696A2 (en) | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases | |
| US20150125390A1 (en) | 18f-labelled folate/antifolate analogues | |
| ES2451642T3 (es) | Derivados de indol tetracíclicos como agentes de formación de imágenes in vivo y que tienen afinidad por receptores de benzodiazepina periféricos (PBR) | |
| KR20170012372A (ko) | 뇌암을 치료하기 위한 화합물 | |
| JP2014193889A5 (enExample) | ||
| RU2006107563A (ru) | Зонды для заболеваний с накоплением амилоида, красители для амилоида, лекарства для лечения и профилактики заболеваний с накоплением амилоида, зонды для диагностики нейрофибриллярных клубков и красители для нейрофибриллярных клубков | |
| JP6987840B2 (ja) | Ｉｄｏ１酵素イメージングのための放射性リガンド | |
| RU2006117819A (ru) | Новые агенты визуализации, содержащие ингибиторы каспазы-3 | |
| JP2013514326A (ja) | 標識インテグリン結合剤 | |
| JP2007500730A5 (enExample) | ||
| JP2014193889A (ja) | 診断用画像及び放射線治療用の葉酸複合体及び対応する金属キレート錯体 | |
| El-Kawy et al. | Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent | |
| CN101885744B (zh) | 99mTc标记肼基烟酰胺基-蝶酰赖氨酸配合物的制备方法 | |
| CN103951668A (zh) | 叶酸衍生物的正电子核素标记物及其应用 | |
| RU2007110372A (ru) | Агенты визуализации, ингибирующие металлопротеиназу | |
| JP2024511374A (ja) | 新規のペプチドベースの診断及び治療剤 | |
| CN101775039B (zh) | 99mTc标记肼基烟酰胺基-叶酸配合物的制备方法及应用 | |
| WO2014122228A1 (en) | Labelled compounds that bind to alpha-v-beta-3 integrin |